BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17494792)

  • 21. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma-release assay prevents unnecessary tuberculosis therapy.
    Schichter-Konfino V; Halasz K; Grushko G; Snir A; Haj T; Vadasz Z; Kessel A; Potasman I; Toubi E
    Isr Med Assoc J; 2015 Apr; 17(4):223-6. PubMed ID: 26040047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.
    Ling DI; Crépeau CA; Dufresne M; Khan S; Quach C; Dendukuri N; Schwartzman K; Menzies D; Lands LC; Pai M
    Pediatr Infect Dis J; 2012 Dec; 31(12):1258-62. PubMed ID: 22828646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
    Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
    Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.
    Arend SM; Thijsen SF; Leyten EM; Bouwman JJ; Franken WP; Koster BF; Cobelens FG; van Houte AJ; Bossink AW
    Am J Respir Crit Care Med; 2007 Mar; 175(6):618-27. PubMed ID: 17170386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
    Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
    Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay.
    Ang M; Htoon HM; Chee SP
    Ophthalmology; 2009 Jul; 116(7):1391-6. PubMed ID: 19576501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Kowada A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update.
    Diel R; Loddenkemper R; Niemann S; Meywald-Walter K; Nienhaus A
    Am J Respir Crit Care Med; 2011 Jan; 183(1):88-95. PubMed ID: 20802162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
    Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
    Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
    James PM; Ganaie FA; Kadahalli RL
    J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis.
    Fox BD; Kramer MR; Mor Z; Preiss R; Rusanov V; Fuks L; Peled N; Haim I; Raz M; Shitrit D
    Lung; 2009; 187(6):413-9. PubMed ID: 19830489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.